Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019

…, NA Acet Ozturk, E Demirdogen… - Internal Medicine …, 2022 - Wiley Online Library
… Our single-centre pilot study determined that total IgE levels may be a negative prognostic
factor for … Our single-centre pilot study determined that total IgE levels may be a negative …

[PDF][PDF] Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019.

…, AG Dilektasli, NAA Ozturk, E Demirdogen… - Internal Medicine …, 2022 - researchgate.net
… Conclusions: Our single-centre pilot study determined that total IgE levels may be a negative
prognostic … Our single-centre pilot study determined that total IgE levels may be a negative …

Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019.

SS Goktas, AO NA, E Demirdogen, F Coskun… - Internal Medicine …, 2022 - europepmc.org
… In the present study, we aim to evaluate the effects of basal serum total immunoglobulin
E (IgE) levels … parameters on the clinical progression of patients hospitalized with COVID‐19. …

Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study

B Wolszczak-Biedrzycka, J Dorf… - Frontiers in …, 2024 - frontiersin.org
… in the acute phase of COVID-19 (18, 19), and this is the first study to evaluate changes in …
be used as prognostic biomarkers for monitoring disease severity in patients with COVID-19…

Plasma markers of COVID-19 severity: a pilot study

J Beimdiek, S Janciauskiene, S Wrenger, S Volland… - … Research, 2022 - Springer
coronavirus disease of 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus … used as a diagnostic marker reflecting the severity and prognosis of COVID-19 [16…

Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study

A Reisner, LS Blackwell, I Sayeed… - Experimental …, 2022 - journals.sagepub.com
… We conclude OPN is a potential biomarker of COVID-19 severity and MIS-… predictive value
of this marker for COVID-19 and MIS-C are areas for future larger prospective research studies

[HTML][HTML] A simple prognostic score based on troponin and presepsin for COVID-19 patients admitted to the emergency department: a single-center pilot study

P Dell'Aquila, P Raimondo, D Orso… - Acta Bio Medica …, 2021 - ncbi.nlm.nih.gov
… -19 disease was also confirmed in a US patient population (… I is a biomarker capable of
predicting COVID-19 patients’ … Presepsin as a predictive biomarker of severity in COVID-19: …

Novel prognostic determinants of COVID-19-related mortality: A pilot study on severely-ill patients in Russia

…, A Evseev, K Popugaev, S Petrikov, E Semina - PLoS …, 2022 - journals.plos.org
… shown to be a prognostic marker of systemic inflammation in various pathological conditions
[32, 33]. Moreover, NLR was found to have a high prognostic value in COVID-19 patients …

Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study

…, İ Anaklı, G Alay, V Tuna, E Çeliksoy… - … medical research …, 2021 - Taylor & Francis
… to our local SIC had any measurable effect on clinical outcomes and biomarkers in these …
were compared regarding baseline characteristics, prognostic factors, treatments, diagnostics …

… and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study

, … Vall d'Hebron Group for the study of COVID-19 … - Frontiers in …, 2022 - frontiersin.org
… house PCR assay with primers and probes from 2019-nCoV CDC PCR panel, using …
COVID-19 could be simplified, but additional biomarkers with real independent additional predictive